(Health-NewsWire.Net, April 25, 2017 ) Middle-East and Africa Nuclear medicine and Diagnostic Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 21.45% to reach USD 2.73 billion by 2020, from USD 1.03 billion in 2016.
Nuclear medicine uses a few portions of radioactive particles called radiotracers which are commonly inserted into the bloodstream, puffed or consumed. The radiotracer passes through the area which is being tested and gives out energy in the form of gamma rays which is detected via special camera and a computer which forms images of the internal body. Nuclear medicine imaging is capable to identify the diseases in its earlier stage and also provides unique details which cannot be identified by other imaging procedures. In many diagnostic centres, nuclear medicine images can be overlapped with computed tomography or magnetic resonance imaging for special views which is known as image fusion. For more decisive information and diagnosis, views permit the information from two different examinations to be correlated and explained in one image. Imaging market is emerging but MRI/PET is not readily available at present.
Get free sample report at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-nuclear-medicine-diagnostics-market-128/request-sample
Key factors which affect and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are
Increasing usage of SPECT and PET for scanning. Increasing cancer and cardiac diseases. Advancements in immunotherapy-based targeted for cancer treatment. Advances made for radiotracers. Rising number of diagnostic imaging techniques Half-life of radiopharmaceuticals is short. Stringent Government Regulations
For granular level understanding the Nuclear medicine and Diagnostic Market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Type: SPECT: o Technetium-99m o Thallium-201 o Gallium-67 o Iodine-23 o Others PET: o Fluorine-18 o Rubidium-82 o Others
Based on Application: Cardiology Lymphoma Thyroid Neurology Oncology Others
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, Israel, KSA, UAE, Nigeria and Algeria.
Some of the key players that operate in the Middle-East and Africa Nuclear Medicine and Diagnostic market include Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc. GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Hologic Inc., Fujifilm Corporation, and Shimadzu Corporation.
The Middle-East and Africa Nuclear Medicine and Diagnostic market report offers wide-range of scope:
Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole
Know more about key areas of industry growth via detailed Segment-level analysis on basis of type and application along with market size forecasts and y-o-y estimations
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Diagnostics Market:
Companion Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/
In-vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-in-vitro-diagnostics-market-146/
Preclinical In-vivo Imaging Market: http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/
Ultrasound Devices Market: http://www.marketdataforecast.com/market-reports/global-ultrasound-devices-market-575/
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|